Effect of carrier particle shape on dry powder inhaler performance

Allen, 1981 Ansari, 2008, The effect of granule microstructure on dissolution rate, Powder Technol., 181, 104, 10.1016/j.powtec.2006.12.012 Barrett, 1980, The shape of rock particles, a critical review, Sedimentology, 27, 291, 10.1111/j.1365-3091.1980.tb01179.x Begat, 2004, The cohesive–adhesive balances in dry powder inhaler formulations. I. Direct quantification by atomic force microscopy, Pharm. Res., 2, 1591, 10.1023/B:PHAM.0000041453.24419.8a Bell, 2006, Dry powder aerosols. I. A new powder inhalation device, J. Pharm. Sci., 60, 1559, 10.1002/jps.2600601028 Berard, 2002, Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM, Int. J. Pharm., 232, 213, 10.1016/S0378-5173(01)00913-9 Bosquillon, 2001, Comparison of particle sizing techniques in the case of inhalation dry powders, J. Pharm. Sci., 90, 2032, 10.1002/jps.1154 Bosquillon, 2004, Aerosolization properties, surface composition and physical state of spray-dried protein powders, J. Control. Release, 99, 357, 10.1016/j.jconrel.2004.07.022 Burger, 2000, Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol, J. Pharm. Sci., 89, 457, 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G Byron, 1994, Recommendations of the USP advisory panel on aerosols on the USP general chapters on aerosols (601) and uniformity of dosage units (905), Pharm. Forum, 20, 7477 Byron, 1990, Efficiency of aerosolization from dry powder blends of terbutaline sulfate and lactose NF with different particle-size distributions, Pharm. Res., 7, 81 Campbell Roberts, 2002, Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry – exploring preferred orientation effects, J. Pharm. Biomed. Anal., 28, 1149, 10.1016/S0731-7085(02)00053-5 Carr, 1965, Classifying flow properties of solids, Chem. Eng., 72, 169 Carr, 1965, Evaluating flow properties of solids, Chem. Eng., 72, 163 Chew, 2001, Use of solid corrugated particles to enhance powder aerosol performance, Pharm. Res., 18, 1570, 10.1023/A:1013082531394 Cline, 2002, Predicting the quality of powders for inhalation from surface energy and area, Pharm. Res., 19, 1274, 10.1023/A:1020338405947 Debord, 1987, Study of different crystalline forms of mannitol: comparative behaviour under compression, Drug. Dev. Ind. Pharm., 13, 1533, 10.3109/03639048709068679 Dickhoff, 2006, The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation, Int. J. Pharm., 327, 17, 10.1016/j.ijpharm.2006.07.017 Edwards, 1997, Large porous particles for pulmonary drug delivery, Science, 276, 1868, 10.1126/science.276.5320.1868 Elajnaf, 2006, Electrostatic characterisation of inhaled powders: effect of contact surface and relative humidity, Eur. J. Pharm. Sci., 29, 375, 10.1016/j.ejps.2006.07.006 Feeley, 1998, Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation, Int. J. Pharm., 172, 89, 10.1016/S0378-5173(98)00179-3 Ferron, 1994, Aerosol properties and lung deposition, Eur. Respir. J., 7, 1392, 10.1183/09031936.94.07081392 Frijlink, 2004, Dry powder inhalers for pulmonary drug delivery, Edd., 1, 67 Fukuoka, 1992, Cohesion of particulates solids. VIII. Influence of particle shape on compression by tapping, Chem. Pharm. Bull., 40, 2805, 10.1248/cpb.40.2805 Ganderton, 1992, Dry powder inhalers, Adv. Pharm. Sci., 6, 165 Hamishehkar, 2010, Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin, Int. J. Pharm., 389, 74, 10.1016/j.ijpharm.2010.01.021 Haque, 2005, Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose, Carbohydr. Res., 340, 293, 10.1016/j.carres.2004.11.026 Hassan, 2009, Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties, AAPS Pharm. Sci. Technol., 10, 1252, 10.1208/s12249-009-9313-3 Hausner, 1967, Friction conditions in a mass of metal powder, Powder Metall., 13, 7 Hawe, 2006, Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol–sucrose–NaCl formulations, Eur. J. Pharm. Biopharm., 64, 316, 10.1016/j.ejpb.2006.06.002 Hersey, 1975, Ordered mixing: a new concept in powder mixing practice, Powder Technol., 11, 41, 10.1016/0032-5910(75)80021-0 Heyder, 1986, Deposition of particles in the human respiratory tract in the size range 0.005–15μm, J. Aerosol Sci., 17, 811, 10.1016/0021-8502(86)90035-2 Hickey, 1992, Use of particle morphology to influence the delivery of drug from dry powder aerosols, J. Biopharm. Sci., 3, 2 Hino, 1998, Particle design of wogon extract dry powder for inhalation aerosols with granulation method, Int. J. Pharm., 168, 59, 10.1016/S0378-5173(98)00083-0 Iida, 2003, Preparation of dry powder inhalation by surface treatment of lactose carrier particles, Chem. Pharm. Bull., 51, 1, 10.1248/cpb.51.1 Iida, 2001, Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier, Chem. Pharm. Bull., 49, 1326, 10.1248/cpb.49.1326 Iida, 2000, Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS), Yakugaku Zasshi J. Pharm. Soc. Jpn., 120, 113, 10.1248/yakushi1947.120.1_113 Islam, 2004, Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?, Pharm. Res., 21, 492, 10.1023/B:PHAM.0000019304.91412.18 Jiang, 2005, Use of recrystallized lactose as carrier for inhalation powder of interferon α 2b, Pharmazie, 60, 632 Jones, 1970, The optical and crystallographic properties of three phases of mannitol, Microscope, 18, 279 Kaialy, 2011, Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol–acetone, J. Pharm. Sci., 100, 2665, 10.1002/jps.22483 Kaialy, 2010, Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler, Colloids Surface B-Biointerfaces, 79, 345, 10.1016/j.colsurfb.2010.04.016 Kaialy, 2010, The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient, Int. J. Pharm., 392, 178, 10.1016/j.ijpharm.2010.03.057 Kaialy, W., Martin, G.P., Ticehurst, M.D., Larhrib, H., Kolosionek, E., Nokhodchi, A. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers, Colloids Surface B-Biointerfaces, doi:10.1016/j.colsurfb.2011.08.019, in press. Kaialy, 2011, Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers, AAPS J., 13, 30, 10.1208/s12248-010-9241-x Kawashima, 1998, Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate, Int. J. Pharm., 172, 179, 10.1016/S0378-5173(98)00202-6 Kumar, 2004, Direct-write deposition of fine powders through miniature hopper-nozzles for multi-material solid freeform fabrication, Rapid Prototyping J., 10, 14, 10.1108/13552540410512499 Kumar, 2001, Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions, AAPS Pharm. Sci. Technol., 2, 22, 10.1208/pt020207 Larhrib, 1999, The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate, Int. J. Pharm., 191, 1, 10.1016/S0378-5173(99)00164-7 Lippmann, 1990, Particle loading in the human lung–human experience and implications for exposure limits, J. Aerosol Med., 3, 155, 10.1089/jam.1990.3.Suppl_1.S-155 Louey, 2002, Particle interactions involved in aerosol dispersion of ternary interactive mixtures, Pharm. Res., 19, 1524, 10.1023/A:1020464801786 Louey, 2003, Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures, Int. J. Pharm., 252, 87, 10.1016/S0378-5173(02)00621-X Malcolmson, 1998, Dry powder formulations for pulmonary delivery, Pharm. Sci. Technol. Today, 1, 394, 10.1016/S1461-5347(98)00099-6 Martonen, 1992, Use of analytically defined estimates of aerosol respirable fraction to predict lung deposition patterns, Pharm. Res., 9, 1634, 10.1023/A:1015880828704 Mitchell, 2003, Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations, J. Aerosol Med., 16, 341, 10.1089/089426803772455622 Murakoshi, 2005, Effect of physical properties of carrier particles on drug emission from a dry powder inhaler device, J. Drug Deliv. Sci. Technol., 15, 223, 10.1016/S1773-2247(05)50036-4 Nakate, 2004, Formulation development of inhalation powders for FK888 with carrier lactose using spinhaler® and its absorption in healthy volunteers, J. Control. Release, 97, 19, 10.1016/j.jconrel.2004.01.028 Neumann, 2002, A comparative study of various size distribution, Part. Part. Syst. Character., 19, 17, 10.1002/1521-4117(200204)19:1<17::AID-PPSC17>3.0.CO;2-1 Neumann, 1967, The flow properties of powders, Adv. Pharm. Sci., 2, 191 Otsuka, 1988, Measurement of the adhesive force between particles of powdered materials and a glass substrate by means of the impact separation method. III. Effect of particle shape and surface asperity, Chem. Pharm. Bull., 36, 741, 10.1248/cpb.36.741 Price, 1989, Salbutamol in the 1980. A reappraisal of its clinical efficacy, Drugs, 38, 77, 10.2165/00003495-198938010-00004 Prime, 1997, Review of dry powder inhalers, Adv. Drug Deliv. Rev., 26, 51, 10.1016/S0169-409X(97)00510-3 Rabbani, 2005, The influence of formulation components on the aerosolisation properties of spray-dried powders, J. Control. Release, 110, 130, 10.1016/j.jconrel.2005.09.004 Raghavan, 2000, Articles-physical chemistry of surfaces and interfaces-morphology of crystals of a-lactose hydrate grown from aqueous solution, J. Phys. Chem. B, 104, 12256, 10.1021/jp002051o Rajniak, 2007, Experimental study of wet granulation in fluidized bed: impact of the binder properties on the granule morphology, Int. J. Pharm., 334, 92, 10.1016/j.ijpharm.2006.10.040 Raula, 2007, Study of the dispersion behaviour of L-leucine containing microparticles synthesized with an aerosol flow reactor method, Powder Technol., 177, 125, 10.1016/j.powtec.2007.03.016 Rowe, 2003 Sethuraman, 2002, Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug, AAPS Pharm. Sci. Technol., 3, 7, 10.1208/pt030428 Seville, 2002, Preparation of dry powder gene delivery systems for pulmonary administration, Proc. Drug Deliv. Lungs, 172 Sharma, 2004, Effect of vacuum drying on protein-mannitol interactions: the physical state of mannitol and protein structure in the dried state, AAPS Pharm. Sci. Technol., 5, 58 Smyth, 2005, Carriers in drug powder delivery: implications for inhalation system design, Am. J. Drug Del., 3, 117, 10.2165/00137696-200503020-00004 Stahlhofen, 1980, Experimental determination of the regional deposition of aerosol particles in the human respiratory tract, Am. Ind. Hyg. Assoc. J., 41, 385, 10.1080/15298668091424933 Staniforth, 1982, Interparticle forces in binary and ternary ordered powder mixes, J. Pharm. Pharmacol., 34, 141, 10.1111/j.2042-7158.1982.tb04210.x Steckel, 1997, In vitro evaluation of dry powder inhalers. II. Influence of carrier particle size and concentration on in vitro deposition, Int. J. Pharm., 154, 31, 10.1016/S0378-5173(97)00115-4 Steckel, 2004, Solid dosage selecting lactose for a capsule-based dry powder inhaler, Pharm. Technol. Eur., 16, 23 Tang, 2009, Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets, Int. J. Pharm., 367, 51, 10.1016/j.ijpharm.2008.09.024 Telko, 2005, Dry powder inhaler formulation, Respir. Care, 50, 1209 Timsina, 1994, Drug delivery to the respiratory tract using dry powder inhalers, Int. J. Pharm., 101, 1, 10.1016/0378-5173(94)90070-1 Tinke, 2008, Particle shape and orientation in laser diffraction and static image analysis size distribution analysis of micrometer sized rectangular particles, Powder Technol., 186, 154, 10.1016/j.powtec.2007.11.017 Traini, 2008, The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations, Drug Dev. Ind. Pharm., 34, 992, 10.1080/03639040802154889 USP Pharmacopeia, 2003 Van Kreveld, 1965, Measurement of crystal growth rates in lactose crystals, J. Dairy Sci., 48, 259, 10.3168/jds.S0022-0302(65)88213-3 Vanbever, 1999, Formulation and physical characterization of large porous particles for inhalation, Pharm. Res., 16, 1735, 10.1023/A:1018910200420 Velaga, 2004, Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process, Eur. J. Pharm. Sci., 21, 501, 10.1016/j.ejps.2003.11.006 Walter-Levy, 1968, Cristallochimie-sur les variétés cristallines du D-mannitol, CR Acad. Sci. Paris Ser. C, 267, 1779 Yoshinari, 2002, Moisture induced polymorphic transition of mannitol and its morphological transformation, Int. J. Pharm., 247, 69, 10.1016/S0378-5173(02)00380-0 Young, 2004, The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphate, Eur. J. Pharm. Sci., 22, 235, 10.1016/j.ejps.2004.03.006 Young, 2005, The influence of dose on the performance of dry powder inhalation systems, Int. J. Pharm., 296, 26, 10.1016/j.ijpharm.2005.02.004 Yu, 1999, Existence of a mannitol hydrate during freeze-drying and practical implications, J. Pharm. Sci., 88, 196, 10.1021/js980323h Zeng, 2001 Zeng, 2001, Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery, J. Pharm. Sci., 90, 1424, 10.1002/jps.1094 Zeng, 2000, The influence of carrier morphology on drug delivery by dry powder inhalers, Int. J. Pharm., 200, 93, 10.1016/S0378-5173(00)00347-1